Clinical Tiral of Suhuang Zhike Capsule in Treating Cough after Thoracoscopic Pneumonectomy for Early Non-small Cell Lung Cancer
- Conditions
- Cough after non-small cell lung thoracoscopic pneumonectomy
- Registration Number
- ITMCTR2100005223
- Lead Sponsor
- Peking University people's Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. Patients who underwent thoracoscopic sublobe, lobe, compound lobe or pneumonectomy, with or without mediastinal lymph node resection;
2. The postoperative pathological diagnosis was primary non-small cell lung cancer stage I, stage II or carcinoma in situ;
3. Meet the diagnosis of postoperative cough and cough occurs within one month after surgery;
4. It conforms to the syndrome differentiation criteria of wind evil invading the lung and lung qi losing circulation;
5. Aged 18-65 years old male or female;
6. Day cough symptom score >=2 points and/or night cough symptom score >=2 points;
7. Voluntary participation in the clinical trial, informed consent and signature of informed consent.
1. Cough not caused by early postoperative non-small cell lung cancer;
2. Those who meet the diagnostic criteria for non-small cell lung cancer but have undergone surgery, radiotherapy, chemotherapy, or targeted therapy;
3. Those who have a history of allergies to the composition of Suhuang Zhike Capsule;
4. Those who are participating in other clinical trials within 4 weeks before enrollment
5. Cough caused by bronchitis;
6. Patients who have had a cough before thoracoscopic pneumonectomy.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method CQ;Renal function;TCM Syndrome Score Table;Routine urine examination;Routine stool test;Routine blood test;Chest X-ray examination;12-lead electrocardiogram;Cough Symptom Score Table;Liver function;
- Secondary Outcome Measures
Name Time Method